Cargando…

Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

BACKGROUND: Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence, ET-resistant (ET-R) HR+ BCa presents a therapeutic chall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahnassy, Shaymaa, Thangavel, Hariprasad, Quttina, Maram, Khan, Ashfia Fatima, Dhanyalayam, Dhanya, Ritho, Joan, Karami, Samaneh, Ren, Jing, Bawa-Khalfe, Tasneem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501670/ https://www.ncbi.nlm.nih.gov/pubmed/32948192 http://dx.doi.org/10.1186/s12964-020-00649-z

Ejemplares similares

Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell Transformation
por: Karami, Samaneh, et al.
Publicado: (2017)

Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer
por: Quttina, Maram, et al.
Publicado: (2023)

SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy
por: Lin, Feng-Ming, et al.
Publicado: (2016)

Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells
por: Premaratne, Asitha, et al.
Publicado: (2023)

Diets Differently Regulate Tumorigenesis in Young E0771 Syngeneic Breast Cancer Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

SENP1 regulates PTEN stability to dictate prostate cancer development
por: Bawa-Khalfe, Tasneem, et al.
Publicado: (2016)

Sex Differences in Cardiac Pathology of SARS-CoV2 Infected and Trypanosoma cruzi Co-infected Mice
por: Dhanyalayam, Dhanya, et al.
Publicado: (2022)

Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

Diets Differently Regulate Pulmonary Pathogenesis and Immune Signaling in Mice during Acute and Chronic Mycobacterium tuberculosis Infection
por: Oswal, Neelam, et al.
Publicado: (2023)

Host Metabolic Changes during Mycobacterium Tuberculosis Infection Cause Insulin Resistance in Adult Mice
por: Oswal, Neelam, et al.
Publicado: (2022)

Constitutively Active Androgen Receptor in Hepatocellular Carcinoma
por: Montgomery, Emma J., et al.
Publicado: (2022)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
por: Lukowicz, Céline, et al.
Publicado: (2019)

Deletion of Nuclear Receptor Constitutive Androstane Receptor CAR Increases Anxiety and Lowers Androgen Levels
por: Hernandez, Juan P, et al.
Publicado: (2021)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
por: Henzler, Christine, et al.
Publicado: (2016)

Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis
por: Oduwole, Olayiwola O., et al.
Publicado: (2018)

The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling
por: Faria, Michelle, et al.
Publicado: (2018)

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients
por: Lundin, K B, et al.
Publicado: (2011)

Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
por: Ali, Azlena, et al.
Publicado: (2015)

Author Correction: Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
por: Lukowicz, Céline, et al.
Publicado: (2020)

Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus
por: Sakkiah, Sugunadevi, et al.
Publicado: (2017)

Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells
por: Cottard, Félicie, et al.
Publicado: (2013)

AB157. The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells
por: Wu, Dan, et al.
Publicado: (2016)

Impact of Neonatal Manipulation of Androgen Receptor Function on Endocrine-Metabolic Programming in the Juvenile Female Rat
por: Ongaro, Luisina, et al.
Publicado: (2013)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction
por: Wahl, Joel, et al.
Publicado: (2018)

Endocrine Disruption: Structural Interactions of Androgen Receptor against Di(2-ethylhexyl) Phthalate and Its Metabolites
por: Beg, Mohd Amin, et al.
Publicado: (2020)

In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
por: Tachachartvanich, Phum, et al.
Publicado: (2022)

Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
por: He, Yundong, et al.
Publicado: (2018)

PMON251 Loss of Constitutive Androstane Receptor, CAR reduces the serum androgens levels and alters reproductive function
por: Asokakumar, Anjana, et al.
Publicado: (2022)

Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2023)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Androgen receptor epigenetics
por: Cai, Changmeng, et al.
Publicado: (2013)

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
por: Olsen, Jan Roger, et al.
Publicado: (2016)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
por: Pizon, Monika, et al.
Publicado: (2018)

Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors
por: Liu, Dehong, et al.
Publicado: (2019)

Structural Aspects of Potential Endocrine-Disrupting Activity of Stereoisomers for a Common Pesticide Permethrin against Androgen Receptor
por: Sheikh, Ishfaq Ahmad, et al.
Publicado: (2021)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uolf2dd02mr0m2ek91t45om6ra